Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suprascapular nerve block for post-stroke hemiplegic shoulder pain
ACTRN12609000621213Phase 2Completed
- Sponsor
- Maria Crotty
- Start
- Jun 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of methylprednisolone, bupivacaine, lidocaine and sodium chloride in stroke (2 arms), sponsored by Maria Crotty. Primary endpoint: Visual Analogue Scale for shoulder pain at 12 weeks. Started Jun 2009; status: completed.
02
Drugs
methylprednisolonebupivacainelidocainesodium chloride
03
Conditions
stroke
Beyond the preview
Go deeper on ACTRN12609000621213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000621213.